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Abstract: Inguinal hernia repair is one of the most common surgeries performed worldwide. With 
the success of modern hernia repair techniques, recurrence rates have significantly declined, with 
a lower incidence than the development of chronic postherniorrhaphy inguinal pain (CPIP). The 
avoidance of CPIP is arguably the most important clinical outcome and has the greatest impact 
on patient satisfaction, health care utilization, societal cost, and quality of life. The etiology of 
CPIP is multifactorial, with overlapping neuropathic and nociceptive components contributing 
to this complex syndrome. Treatment is often challenging, and no definitive treatment algorithm 
exists. Multidisciplinary management of this complex problem improves outcomes, as treatment 
must be individualized. Current medical, pharmacologic, interventional, and surgical manage-
ment strategies are reviewed.
Keywords: inguinodynia, chronic postherniorrhaphy inguinal pain, inguinal hernia
Introduction
Inguinal hernia repair is one of the most common surgical procedures in the world. 
Annually, more than 20 million inguinal hernia repairs are conducted worldwide, and 
in the US alone the number reaches 800,000.1–4 In industrialized countries, lifetime 
risk for undergoing reparative surgery of inguinal hernia has been estimated to be 27% 
for men, and 3% for women.5 For a majority of patients, the operative correction of an 
inguinal hernia is successful with a minimum of postoperative sequelae, followed by 
a few weeks convalescence6 and no long-term complications. However, considering 
the vast number of patients undergoing inguinal hernia repair, any, even rare, severe 
long-term complication would be of great impact.
The techniques of operative repair, or herniorrhaphy, have been refined over the last 
decades and have resulted in open and laparoscopic tension-free approaches utilizing 
advanced prosthetic mesh-material as gold standard. Consequently, hernia recurrence 
rates have decreased dramatically (1%–5%),7 and today, chronic pain is instead recog-
nized as the most significant complication. Chronic postsurgical pain (CPSP) has been 
defined as pain that develops after surgical intervention and lasts for at least 2 months, 
other causes of pain excluded.8 CPSP has been historically reported with every common 
operation, including appendectomy, cholecystectomy, and cesarian section.
In the case of chronic postherniorrhaphy inguinal pain (CPIP), taking into account 
postoperative inflammatory processes, 3–6 months is usually the definition for 
chronicity. The reported frequency of chronic pain following inguinal hernia repair 
varies considerably between studies depending on differing definitions, end points, 
and methodologies, but the estimated risk of moderate to severe chronic pain 
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is 10%–12%.9–11 The rate of chronic pain affecting activities 
of daily life or employment is agreed to be 0.5%–6.0%,4 
which although being a conservative estimate constitutes 
an enormous individual and societal burden, translating to 
4,000–48,000 new cases in the US annually, making it a 
health concern of tremendous scope.
The etiology and source of CPIP is complex and includes 
hernia recurrence, tissue inflammation, meshoma, and 
inguinal nerve injury or entrapment.12,13 Many patients suf-
fer from neuropathic pain characterized by negative sensory 
phenomena, dysesthesia, allodynia, hyperalgesia, and non-
neuropathic deep inflammatory pain.14 Peripheral and central 
sensitization, maladaptive neuronal plasticity, and neuroim-
mune alterations complicate the clinical picture and treat-
ment of CPSP.15,16 Central sensitization, as it may relate to 
CPIP and other CPSP syndromes, has been shown in animal 
models to be modulated by NMDA (N-methyl-D-aspartate) 
and adenylate cyclase activation and upregulation following 
an inflammatory stimulus. This neuronal plasticity leads to 
the development of “pain vulnerability” or “hyperalgesic 
 priming” which may represent a surrogate of pain chroniciza-
tion in the transition from acute to chronic pain.17,18
CPIP is one of many significant pain syndromes that 
are related to surgical procedures. Mastectomies, thora-
cotomies, major abdominal surgeries, and lumbar spine 
surgery are all surgical procedures that have been shown 
to have higher rates of CPSP.19–21 Depending on the surgi-
cal procedure, the  incidence of CPSP is 4%–50%,19 thus 
indicating the importance of its prevention, management, 
and treatment.
Severe chronic pain is a devastating condition, arguably 
constituting its own neurological disease entity.22 Suffering is 
caused through painful symptoms, but also from associated 
affective disorders such as anxiety and depression, cognitive 
impairment, and somatic comorbidities.22,23 Sleep deprivation 
is a common consequence of chronic pain, contributing to 
worsening of the pain,22,24 and CPIP-patients have an overall 
significantly reduced quality of life.25 The exact socioeco-
nomic burden of patients suffering from CPIP has not been 
calculated, but the total annual direct and indirect cost of 
a diagnosis related to chronic pain may range somewhere 
between US$9,00026 and US$40,000 in the case of severe 
postsurgical neuropathic pain.27
Considering how common, detrimental, and costly CPIP 
is, prevention and skilled treatment of this condition is of 
utmost importance. This review will explain the multifacto-
rial etiologies underlying CPIP, outline risk factors, describe 
symptomatology and evaluation, and most importantly, 
provide evidence-based concepts on current and prospec-
tive pharmacological, interventional, and surgical treat-
ments of CPIP.
Methods
This is a comprehensive review of the literature from 
1966 through October 2013, including reports, systematic 
reviews, scientific studies, and other literature concerning 
chronic pain following inguinal herniorrhaphy. The data 
were  collected using the PubMed search engine (National 
Center for  Biotechnology Information, US National Library 
of Medicine, USA), Cochrane Reviews, and a manual 
search of all pertinent references in the literature. The 
database searches were performed in September–October 
2013, employing the keywords chronic, persistent, inguinal, 
groin, herniorrhaphy, hernioplasty, hernia repair, pain, and 
treatment in various combinations and also combined with 
specific treatment modalities. Relevant ongoing trials were 
searched using national and international trial registers 
(http://clinicaltrials.gov, https://www.clinicaltrialsregister.
eu), and main investigators were contacted for further 
information. The language of publications and trials was 
not an exclusion criterion.
Etiology
The exact etiology of CPIP is complex and variable, with 
many patients exhibiting signs and symptoms that suggest 
multiple as opposed to singular etiologies. Classically, the 
differing etiologies can be explained by separating them into 
the differing types of pain encountered in CPIP:  neuropathic, 
non-neuropathic, somatic, and visceral pain. The significant 
overlap and combinations of these types of pain makes diag-
nosis and treatment of CPIP a significant challenge. 
Neuropathic pain in CPIP is thought to arise from dam-
age or trauma to the inguinal nerves. The resultant pain 
usually develops in the sensory distribution of the affected 
nerve(s). The inguinal nerves that are involved in causing 
CPIP are the iliohypogastric nerve (IHN), ilioinguinal nerve 
(IIN), the genital branch of the genitofemoral nerve (GFN), 
and more rarely, the femoral branch of the GFN or the lat-
eral femoral cutaneous nerve. Damage to these nerves can 
occur intraoperatively or postoperatively. Intraoperatively, 
nerves can be damaged by surgical manipulation, but also 
by stretching, crushing, electrical/thermal damage, partial 
or complete transection, becoming entrapped in suture 
during an open repair, or entrapment in tacks, suture, or 
fixation used during a laparoscopic repair. Postoperatively, 
nerves can become damaged due to envelopment within 
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a meshoma, irritation secondary to an excessive fibrotic 
reaction, or inflammatory processes such as granuloma or 
neuroma formation.10,28
Causes of non-neuropathic pain include hernia recur-
rence, excessive scar tissue formation, pain from the bulk 
of the mesh, meshoma formation,12 or mesh-related excess 
 fibrosis.29 A well-described CPIP pain syndrome that falls 
under the designation of somatic pain is periostitis pubis, 
most commonly due to deeply placed anchoring or periosteal 
anchoring of the mesh near the pubic tubercle.10,28,30,31 
 Visceral pain may arise from intestinal involvement with 
recurrence, incarceration, or mesh adherence or may be 
related to the spermatic cord (funiculodynia) or other 
periurethral  structures, including venous congestion of 
the spermatic cord, dyssynergia of the ejaculatory effector 
muscles, stricture of the spermatic duct, or twisting of the 
spermatic cord.10,28,31 Centralization of pain and hyperalgesic 
priming is known to happen with any inflammatory insult, 
and this sensitization can last months after trauma or sur-
gery, even if the patient has minimal reported pain.19,20 The 
inflammatory response to surgery may lead to centraliza-
tion of pain through microglial activation and peripheral 
nociceptor activity predisposing toward “chronification of 
pain”.17 Homeostasis is provided through endogenous opi-
oid and mu-opioid receptor constituent activity. However, 
stress in the postoperative period can lead to a disruption 
of this system, thus leading to latent reactivation of hyper-
algesia and, theoretically, to the transition from acute to 
chronic pain.19,20
Risk factors
Several preoperative, perioperative, and postoperative risk 
factors for the development of CPSP have been identified.1 
All have not been thoroughly studied for CPIP, but an 
increasing number of studies support several of the listed 
factors (Table 1). In particular, two reviews examining publi-
cations on CPIP up until 2004,9,10 data from nationwide hernia 
databases in Scandinavian countries,3,35,36 Scotland,24 recent 
systematic reviews and meta-analyses,11,37–41 and a thorough 
prospective study by Aasvang et al42 provide substantial 
information. Table 1 shows known risk factors for CPIP.
Young age and female sex are two independent 
demographic risk factors, consistently identified in numerous 
large studies.3,5,9,26,41 Women also seem to report more severe 
acute postoperative pain in general,46 which might be related 
to estrogen modulation of nociceptive processing.47 Although 
obesity has sometimes been denominated a risk factor, no 
firm conclusions can be made.9
Solid evidence underlie psychological and social fac-
tors influencing the development of CPSP (depression, 
 psychological vulnerability, stress, and late return to work),48 
but in the case of CPIP, thorough research in this field has 
not been conducted. In a small prospective cohort study with 
a short follow-up period, two cognitive (lower preoperative 
optimism and lower perceived control over pain) but no sig-
nificant emotional risk factors for CPIP were found.49
High pre- and postoperative pain levels are strong risk 
factors for CPIP.3,9,24,35,36,45 In fact, a high magnitude of pain 
predicts future chronic pain risk consistently throughout the 
field of CPSP, and several mechanisms have been proposed, 
including perioperative nerve damage, sensitization of 
nociceptors in the surgical field, early postoperative ectopic 
activity of injured primary afferents, central sensitization, and 
structural changes in the central nervous system.32
The development of CPIP is independent of technique, 
and identification and protection of the inguinal nerves are 
of upmost importance with all techniques.4 Laparoscopic 
approaches may result in less chronic pain.9,11,35,36,42,50 
However, the incidence of significant pain equilibrates 
over time, and pain after laparoscopic repair remains a 
significant challenge due to positioning of the mesh and 
proximal injury to the inguinal nerves.4,12,46 Mesh has early 
on been implicated as a culprit in the development of CPIP – 
potentially causing both non-neuropathic (meshoma and 
fibrosis) and neuropathic (nerve entrapment) pain – hence 
Table 1 Risk factors for chronic postherniorrhaphy inguinal pain
Preoperative factors
Young age3,9,24,35,36,43
Female sex3,9,24,35,36,43
High pain intensity level (inguinal/elsewhere)3,9,24,35,36,45
Lower preoperative optimism49
impairment of everyday activities42
Operation for a recurrent hernia2,9
Genetic predisposition (DQB1*03:02 HLA haplotype)59
Experimentally induced pain
High pain intensity to tonic heat stimulation42
Perioperative factors
Less experienced surgeon/not dedicated hernia center9
Open repair technique9,11,35,36,42,50
Mesh type: heavyweight (open,37 laparoscopic38)
Mesh fixation: suture (open40,41), staple (laparoscopic39)?
iiN neurolysis in Lichtenstein repair45
Postoperative factors
Postoperative complications (hematoma, infection)35,36
High early postoperative pain intensity9,42
Lower perceived control over pain49
Sensory dysfunction in the groin24,42,45
Note: ? = conflicting opinions/mixed evidence.
Abbreviations: iiN, ilioinguinal nerve; HLA, human leukocyte antigen.
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various mesh materials and ways of fixating them have 
been examined.
Recent systematic reviews and meta-analyses have 
demonstrated significant reduction of CPIP for lightweight 
mesh compared with heavyweight mesh in both open and 
laparoscopic settings.37,38 The mechanism through which 
lightweight mesh reduces CPIP is thought to be greater 
biocompatibility (less inflammatory response) and elasticity 
similar to that of the abdominal wall, reducing stiffness and 
foreign body sensations. Several studies have addressed mesh 
fixation alternatives. At present, while results are mixed, it 
is a reasonable assertion that avoidance of sutures and tacks 
may reduce the incidence of CPIP. In one meta-analysis, glue 
fixation of mesh in open repair was shown to reduce CPIP, 
hematoma, acute postoperative pain, and time to return to 
daily activities.40 However, in another meta-analysis, only 
the latter and early CPIP (3–6 months) were significantly 
affected.41 In two other systematic reviews, it was concluded 
that glue mesh fixation is an interesting alternative, but that 
there is currently insufficient evidence regarding several end 
points due to the low quality of included studies.51,52 Based 
upon current evidence, self-gripping and sutured mesh dem-
onstrate similar CPIP rates.53
Type of anesthesia – general, regional, or local – has 
not been extensively researched in connection to CPIP 
and presently cannot be linked to any significant CPIP 
outcome differences.36 However, it is not recommended 
to utilize regional anesthesia (epidural, spinal) for hernia 
repair, especially among older patients, due to an increased 
risk of urinary retention and other rare, but severe, medical 
complications.54 Local infiltration anesthesia is the preferred 
method for open repair, advantages including early recovery 
and discharge, less complications, improved early pain relief, 
and reduced costs.55–57 Results from a clinical trial studying 
the effect of perioperative infiltration of local anesthesia on 
the development of CPIP are pending (NCT00484731).
An interesting avenue for improving stratification of 
patients into low and high risk groups of developing CPIP 
is through preoperative experimental stimuli. Results from 
response to pain tests may predict 4%–54% of the variance 
in postoperative pain experience.58 Preoperative testing along 
with risk stratification may help to target at-risk patients 
who may benefit from implementation of specific preventive 
analgesic measures.
Finally, evidence from genetic research indicates an impor-
tant role of an individual’s genetic susceptibility – to both gen-
eration and experience of pain, and response to  analgesics – in 
various chronic pain states.16,32 Functional genetic polymor-
phisms have been identified in several genes (eg, COMT 
[encoding catecholamine-O-methyltransferase], MC1R 
[encoding the melanocortin-1 receptor], 5-HTTLPR [encod-
ing the serotonin transporter], IL1B [encoding interleukin 
{IL}-1β], and IL1RN [encoding IL-1 receptor antagonist]), 
and linked directly or indirectly to different pain condi-
tions.32 Dominguez et al59 recently demonstrated that the 
DQB1*03:02 HLA (human leukocyte antigen) haplotype is 
associated with an increased risk of CPIP, and an ongoing 
multicenter Spanish study is studying the role of specific 
genes in the context of CPIP (NCT01510496).
Symptomatology
The etiologies contributing to CPIP are varied and complex 
in nature. Consequently, the symptomatology of CPIP is 
just as complex and variable and is dependent upon the 
type(s) of pain that the patient is suffering from:  neuropathic 
pain, non-neuropathic pain, somatic pain, and/or visceral 
pain. Patients with neuropathic pain may describe having pain 
(neuralgia), reduced sensation (hypoesthesia), increased sen-
sation (hyperesthesia), or a burning sensation (paresthesia). 
 Occasionally, patients with neuropathic pain will report 
pain to a non-painful stimulus (allodynia) or increased pain 
response to a painful stimulus (hyperalgesia). Stabbing, 
burning, pulling, throbbing, shooting, prickling, and sharp 
are descriptors that are commonly used by patients suffering 
from neuropathic pain.30,60 These symptoms can be constant 
or intermittent. Pain can be localized or radiating in nature, 
with common sites of radiating pain being to the scrotum, 
labium, and/or upper thigh.31 Occasionally, a “trigger point” 
will exist and when palpated will cause the patient to expe-
rience the neuropathic pain symptoms. Neuropathic pain 
symptoms typically worsen with ambulation, twisting, or 
stretching of the upper body, stooping or sitting, hyperexten-
sion of the hip, or sexual intercourse and are made better with 
lying down or flexion of the hip and thigh.10,28,31
Non-neuropathic pain in CPIP is typically described as 
a dull ache, typically constant, usually over the entirety of 
the groin area, with no specific trigger point or radiating 
component.28,31 Words typically used to describe this type of 
pain include: gnawing, tender, pounding, or pulling. Somatic 
pain, as discussed previously, is usually localized to the pubic 
tubercle area as the area of maximum  tenderness. Visceral 
pain in CPIP is generally related to sexual dysfunction or 
ejaculatory pain in the region of the superficial ring or the 
testicular/labial region. According to a study performed by 
Loos et al,31 patients with CPIP visceral pain symptoms 
describe them as aching, without a specific trigger point. 
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Those with a history of anterior approach who have vis-
ceral pain have a spermatic cord that is diffusely tender to 
palpation.31
When evaluating a patient with chronic groin pain after 
hernia surgery, it is important to take into consideration 
the breadth of differential diagnoses (surgical, orthopedic, 
neurologic, infectious disease, urologic, or gynecologic), 
despite the inclination to suspect CPIP as the most logical 
cause. Hernia recurrence is a source of chronic pain in this 
population, is relatively easy to evaluate, and should be ruled 
out early in the evaluation.61
Evaluation
The evaluation of a patient with CPIP should characterize 
the cause and type of pain and exclude differential diag-
nostic entities. A detailed history and clinical examination 
is essential. Administration of validated pain, function 
and  quality-of-life instruments such as the Short Form 
McGill Pain Questionnaire (SF-MPQ), Neuropathic Pain 
Questionnaire (NPQ), or Douleur Neuropathique 4  Questions 
(DN4), SF-36 (36-Item Short Form Health Survey), and 
Activity Assessment Scale are recommended. The screening 
tools NPQ and DN4 have high specificity for neuropathic 
pain, and if a neuropathic component is identified, it can 
be further characterized using the NPS (Neuropathic Pain 
Scale) or SF-MPQ-2.62
Tinel’s test (tapping the skin medial to the anterior 
superior iliac spine or over the area of maximum tender-
ness) can reproduce neuropathic pain distributed along the 
sensory innervation of the affected nerve(s). Based on these 
findings, neuropathic, non-neuropathic, or mixed pain can 
be diagnosed. Due to overlapping sensory innervations, 
peripheral communication between IHN, IIN, and GFN nerve 
twigs and common routes of origin, it is very difficult to 
ascertain which nerves are actually involved in the neuralgic 
pain.63–65 Ultrasonography is a common initial modality to 
detect recurrence or meshoma.66 Cross-sectional computed 
tomography (CT) or magnetic resonance imaging (MRI) of 
the abdominal wall may exclude these pathologies and other 
differential diagnoses of CPIP.61 Currently, MRI is considered 
the best valid diagnostic imaging tool for differentiating causes 
of uncertain inguinal pain,67 but results and interpretation is 
radiologist dependent.68 Diagnostic peripheral nerve block or 
paravertebral root block with a local anesthetic may help to 
identify ilioinguinal, iliohypogastric, and/or genitofemoral 
neuralgia. Typically no further guidance is offered through 
other evaluation tools, but when results of nerve blocks are 
equivocal, needle electromyogram might provide additional 
information (eg, through revealing abnormalities and denerva-
tion of the abdominal muscles specific for IHN/IIN-injury).69,70 
Magnetic resonance neurography may identify peripheral 
nerve compression that will improve with surgical treatment 
but is also technique and radiologist dependent.71
Treatment
Multidisciplinary non-interventional  
pain management
CPIP is complex. It is not only a product of neuropathic 
pain and nociceptive components but is also influenced 
and modulated by emotional, cognitive, social, and genetic 
factors. A multimodal, multidisciplinary treatment approach 
is therefore necessary. Neuropathic pain is difficult to treat, 
and the pain is complicated by central sensitization and 
psychological comorbidities. Lacking firm specific CPIP-
evidence-based non-interventional treatment strategies, the 
best conclusions we can currently draw are from small studies 
on CPIP, empiric evidence, and extrapolation of evidence 
from other neuropathic and CPSP conditions.
Non-pharmacological treatment
The perception of pain depends on multiple factors such 
as experience, fears, context, and meaning and can be 
modulated through cognition and emotion. Physiotherapy, 
acupuncture, and mind–body therapies provide ways of 
ameliorating pain conditions and are important cornerstones 
in a multimodal approach.72 No specific studies address 
these therapies in CPIP, but an array of mind–body therapies 
have been shown to improve recovery time and pain follow-
ing surgery and childbirth, for example, and also in other 
chronic pain conditions.73 Certain lifestyle measures such 
as recumbent position or flexion of the hip and thigh might 
provide temporary relief of painful symptoms; it is, however, 
important to avoid harmful inactivity.
Pharmacological treatment
In case of deep, inflammatory non-neuropathic pain, and 
even when neuropathic pain is caused by nerve entrapment 
secondary to inflammation and edema, non-steroidal anti-
inflammatory drugs (NSAIDs) and steroids can be used with 
some degree of success. It is, however, rarely sustainable 
to continue with these medications long-term due to side 
effects. There are no head-to-head comparisons between 
basic analgesics (eg, NSAIDs, steroids, and acetaminophen) 
in the context of CPIP.
Recent guidelines on pharmacological treatment of 
neuropathic pain (International Association for the Study of 
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Pain [IASP],74 European Federation of Neurological  Societies 
[EFNS],75,76 and Canadian Pain Society77)  systematically 
analyze the evidence of various treatment options based on 
randomized clinical trials. Although most available trials have 
investigated neuropathic pain in the context of postherpetic 
neuralgia (PHN) or painful diabetic peripheral neuropathy, 
and follow-up has usually been relatively short (#3 months), 
it is reasonable to extrapolate results between neuropathic 
conditions.78
Presently, it is not possible to rank the pharmacological 
alternatives for the individual patient. It is important to 
choose treatment according to factors including potential 
side effects, concomitant treatment of other comorbidities 
(anxiety, depression, and insomnia), drug interactions, 
risk of abuse, and cost. There are some discrepancies 
between the above-stated guidelines, but all taken together 
and adjusted for the case of CPIP, it is reasonable to start 
with either calcium channel α
2
-δ ligands (gabapentin and 
pregabalin) or antidepressants with both norepinephrine 
and serotonin reuptake inhibition (SSNRIs) (tricyclic anti-
depressants [TCAs]).
Gabapentin and pregabalin are structural analogs of 
GABA (γ-Aminobutyric acid). Titration over a few weeks 
is needed, and most side effects are transient and dose 
dependent. Dizziness and sedation are commonly observed. 
It is hypothesized that α
2
-δ ligands given preoperatively at 
a certain dosage and for an adequate duration might be able 
to diminish postoperative pain and prevent establishment of 
central sensitization; and meta-analysis supports this idea.79 
Unfortunately a trial designed to investigate the effect of 
pregabalin in CPIP was stopped prematurely due to low 
inclusion rate (NCT00772291). There is a general scarcity 
of trials examining pharmacological alternatives in CPIP.80 
In a small suboptimally designed study (utilizing spinal 
anesthesia and lacking comprehensive pain measures), gaba-
pentin administered preoperatively to inguinal hernia repair 
patients was shown to significantly decrease pain scores at 
6 months follow-up – an interesting finding in relation to 
potential prevention of CPIP.81 Considering the difficulties in 
treating CPIP there has been an increasing focus on preven-
tive analgesia; however, a study on tumor necrosis factor-α 
inhibitor etanercept administered preoperatively failed to 
show beneficial long-term results.82
Duloxetine and venlafaxine are SSNRIs ranked as first-
line alternatives by IASP, but second-line by EFNS and the 
Canadian Pain Society. Advantages of TCAs are low cost, 
easy dosing, and beneficial effect on anxiety, depression, 
and sleep; while disadvantages are risk for anticholinergic 
side effects and orthostatic hypotension. There is a risk for 
cardiotoxicity, and due to an association between TCAs 
at dosages $100 mg and sudden death, caution should be 
exercised in patients with a history of ischemic heart disease 
and dosages preferentially held #100 mg.
Opioids and tramadol are considered second-line treat-
ment alternatives for neuropathic pain but can be utilized 
as first-line during episodic exacerbations of severe neu-
ropathic pain or during titration of TCAs, SSNRIs, or α
2
-δ 
ligands. Although opioids provide NNTs (numbers needed 
to treat) equal to TCAs (2–3)83 in various neuropathic pain 
conditions, side-effects and concerns related to long-term 
treatment (immunological, hormonal, opioid-induced hyper-
algesia, abuse, and dependence) limit their long-term use. 
Few alternatives can provide as swift pain relief as opioids, 
and they are often a necessary component of the treatment 
armamentarium. The most common side effects are consti-
pation, nausea, and sedation; prophylactic bowel regimen 
and antiemetic must be considered and add to the cost of 
treatment. There is often a need for combination therapy, 
and the strongest evidence supports TCA-gabapentin or 
gabapentin-opioids.75
In the case of failure of, or contraindication to, first- and 
second-line treatment alternatives, a few other medications 
can be considered, although their evidence in neuropathic 
pain is meager or conflicting. SSRIs (selective serotonin 
reuptake inhibitors) (citalopram and paroxetine), bupropion, 
cannabinoids, anticonvulsants (lamotrigine, oxcarbazepine, 
topiramate, and valproic acid), or dextromethorphan, meman-
tine, clonidine, and mexiletine may be tried, based upon 
patient characteristics and specific circumstances.
Topical medications
Considering the relatively limited anatomical area causing 
pain in CPIP, it is reasonable to attempt a trial of topical 
medications. However, these alternatives may not absorb far 
enough to treat the underlying condition, and at present, no 
firm supportive evidence for lidocaine and capsaicin patches 
exists for CPIP. Lidocaine acts on voltage-gated sodium 
channels on hyperactive or damaged nociceptors, decreasing 
afferent nociceptive input, and has been shown effective in 
PHN and in various types of peripheral neuropathic pain with 
allodynia.84,85 However, in a well-designed small crossover 
trial (n=21) of lidocaine patches (5%) in patients with severe 
CPIP, no reduction of pain ratings compared with placebo 
were found.86
Capsaicin’s analgesic effect is exerted through repeated 
applications causing persistent desensitization. While  awaiting 
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results from a Danish ongoing study examining capsaicin 
patches (8%) in CPIP (NCT01699854), evidence of capsai-
cin’s effect in neuropathic pain has to be derived from other 
pain conditions. In a Cochrane review from 2013, with results 
based on PHN and HIV (human immunodeficiency virus)-
neuropathy, NNTs for at least 30% pain intensity reduction 
week 2–12 were ten and eleven, respectively.87 Based on the 
high cost of repeated applications, scarce evidence and likely 
high NNTs, topical medications may be tried as second-line 
treatment or when the patient’s comorbidities complicate use 
of the first-line alternatives.
Interventional pain management
Overall, there is a paucity of evidence-based medicine 
evaluating the safety and efficacy of interventional pain 
management techniques in the treatment of CPIP. Few well-
designed, randomized, prospective research studies in this 
field have been performed. Most of the available information 
regarding these techniques exists in the form of case reports 
or case series. In the following sections, the most commonly 
employed interventional pain management techniques and 
their respective pertinent available literature and evidence-
based medicine will be reported and discussed.
Nerve blocks
Nerve blocks of the IIN, IHN, and/or GFN have been used 
for both diagnostic and therapeutic purposes in the diagnosis 
and treatment of CPIP. In some studies, they have been used 
preoperatively to determine which patients may potentially 
respond favorably to surgical neurectomy. Historically, these 
nerve blocks were performed using a blind technique, using 
anatomic landmarks as guidance for needle placement. While 
a blind technique for IIN and IHN blocks would still allow 
for administration of the local anesthetic proximal to the site 
of injury, there exists no blind technique that would allow for 
this with the GFN, given its anatomic course.
Recent advances in ultrasound technology and its use in 
regional anesthesia have enabled practitioners to  perform IIN 
and IHN blocks under a direct visualization, with successful 
outcomes reducing risk of intraperitoneal needle placement 
and allowing for a smaller volume of injectate due to 
improved accuracy. While there has been a published case 
report on ultrasound-guided GFN block, the target for needle 
placement was approached lateral to the pubic tubercle, which 
may be too distal when considering a nerve injury or entrap-
ment after open groin hernia repair.88,89 Ultrasound-guided 
techniques for selective block of the GFN proximal to the 
site of nerve injury are not currently described or available.89 
A recent case report describing a CT-guided trans-psoas GFN 
block appears to be a promising technique to safely block 
the GFN proximal to the site of nerve injury.90
Few studies have been performed evaluating the effi-
cacy of ultrasound-guided IIN/IHN blocks in the treatment 
of CPIP, and provide conflicting results.91,92 In a recent 
report by Thomassen et al,92 the authors found ultrasound-
guided IIN/IHN blocks to be effective in treating CPIP with 
successful prolonged pain relief after a median follow-up 
time of 20 months. Despite this finding, they reported that 
they did not find any statistically significant difference in pain 
outcomes when they compared patients who received nerve-
stimulator-guided nerve blocks versus ultrasound-guided 
nerve blocks. Only one randomized, double-blind, placebo-
controlled study has been published to date evaluating the 
efficacy of ultrasound-guided IIN/IHN blocks in the treat-
ment of CPIP.89 Two cohorts of patients (CPIP and healthy 
control groups) were studied in this crossover design trial. 
The results of this study by Bischoff et al89 failed to provide 
substantial evidence to support the use of ultrasound-guided 
IIN/IHN blocks in the diagnosis and treatment of CPIP. 
A study comparing the use of ultrasound-guided IIN/IHN 
blocks to operative neurectomy is currently underway.93
Neurolysis/neuroablative techniques
If nerve blocks have been performed and provided significant 
analgesia but did not provide long-term relief, neuroablative 
techniques such as chemical neurolysis, cryoablation, and 
pulsed radiofrequency (PRF) ablation may be considered 
for longer-lasting effect. While chemical neurolysis using 
phenol or alcohol has been used in the treatment of CPIP,90,94 
most reports on neuroablative techniques include those using 
cryoablation or PRF ablation techniques.
Cryoablation is neurodestructive by means of Wallerian 
degeneration and selectively destroys axons and myelin 
sheaths while leaving the epineurium and perineurium intact. 
The affected axons treated with cryoablation are very unlikely 
to form neuromas, and patients are less likely to develop 
deafferentation pain, both of which have been associated 
with neurectomy or thermal non-PRF ablation. Cryoablation 
has been reported as being a successful mode of analgesia 
for patients with CPIP. Fanelli et al95 reported the use of this 
modality in nine patients, where they performed cryoablation 
of the nerves under direct surgical visualization, and the mean 
overall pain reduction was 77.5%. Campos et al96 published 
the first reported cryoablation of the femoral branch of the 
GFN under ultrasound guidance in a patient with chronic 
inguinal pain; however, this patient did not suffer from 
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CPIP, and thus the applicability of this procedure to the CPIP 
population is unclear.
The use of PRF ablation in the treatment of CPIP has been 
reported in multiple case series97–100 as well as in a recent sys-
tematic review.101 PRF ablation delivers high intensity currents in 
pulses, which allows for heat (typically 42°C) to dissipate during 
the latent phase so that neurodestructive temperatures are not 
obtained, thus lowering the risk of neuroma formation, neuritis-
type reaction, and deafferentation pain. This mild heating of the 
nerve tissue is thought to temporarily block nerve conduction; 
however, the exact mechanism by which PRF ablation provides 
analgesia is unclear. Rozen and Ahn97 and Rozen and Parvez98 
described in two published case series (of the same patient 
cohort) the use of PRF ablation of the T12, L1, and L2 lumbar 
nerve roots for treatment of CPIP. In these repeat publications, 
the five patients had 75%–100% pain reduction that lasted 
6–9 months, leading the authors to conclude that this modality 
is a potentially efficacious treatment option for patients suffering 
from CPIP. In the published case series by Cohen and Foster,99 
three patients with chronic groin pain (two of them were CPIP) 
underwent either IIN and/or IHN or GFN PRF ablation after hav-
ing successful diagnostic blocks. Compared with the Rozen and 
Ahn, and Rozen and Parvez studies,97,98 the PRF ablation in the 
study by Cohen and Foster,99 was performed peripherally based 
on anatomic location of these nerves in the groin, and correct 
needle placement was confirmed using sensory stimulation. All 
three of these patients reported continued complete pain relief at 
6 months. Mitra et al100 published a single case report on the use 
of PRF ablation for a patient with non-CPIP ilioinguinal neu-
ralgia. Similarly to Cohen and Foster,99 they report performing 
PRF ablation peripherally at the anatomic location of the nerves 
in the groin, using sensory stimulation as confirmation for cor-
rect needle placement. In this study, they describe a significant 
reduction in pain score (from VAS [visual analog scale] 8/10 to 
3/10) that persisted at a 3-month follow-up.100
Werner et al101 recently published a systematic review of 
the available data on PRF ablation in the treatment of CPIP. 
They report that there is a limited level of evidence to sup-
port the use of PRF ablation in the management of CPIP, 
stating that the evidence is of low quality and the strength 
of recommendation is weak to moderate. They propose 
improved scientific rigor and requirements for further PRF 
ablation studies to fully examine the safety and efficacy of 
this interventional technique.
Neuromodulation
For some patients, their CPIP will be refractory to 
 pharmacologic, interventional, and possibly even 
 surgical treatment. Neuromodulation techniques, either 
peripheral nerve field stimulation (PNFS) or spinal cord 
stimulation (SCS), may be considered for use in a select 
group of patients when all other conventional treatments 
have failed. Historically, the gate control theory of pain was 
used to describe the mechanism by which SCS and PNFS 
provided analgesia; however, currently, the exact neurophysi-
ologic mechanisms of action for both of these modalities 
is not yet completely understood.102,103 PNFS and SCS are 
implantable devices that provide pain relief by producing 
gentle paresthesias in the concordant areas of pain. Multiple 
case reports or case series of either separate PNFS,104–109 
SCS,110–112 or combined PNFS and SCS113 have been pub-
lished, all with compelling and successful results. Patient 
selection appears to play a large role in the success of these 
modalities. A few authors have recommended a stringent and 
selective screening process that advocates for the selection 
of well-motivated and relatively young patients who are not 
involved in litigation, have success with a pre-implantation 
trial period, have favorable spinal anatomy (which would 
improve easier placement of SCS compared with those with 
unfavorable anatomy or prior spine surgery), and pass a pre-
implantation psychiatric evaluation.105,112 Further large-scale 
studies may allow for improved evidence and strength of 
recommendation for these two promising modalities.
Surgical pain management
While the majority of patients with CPIP can be managed 
with pharmacologic, interventional, and behavioral measures, 
those refractory to a systematic regimen of diagnostic and 
interventional measures may be considered for operative 
remediation. Successful outcomes, however, are entirely 
dependent upon choosing patients with discrete, neuroana-
tomic problems that may be corrected with surgery.1,4,114,115 
Failure of conservative measures, in and of itself, is not an 
indication for further surgery. There is no level 1 or 2 evi-
dence regarding the operative management of inguinodynia, 
and best available recommendations are derived from case 
reports, case series, expert opinion, and expert consensus.4 
Development of inguinodynia is independent of the method 
of hernia repair,3,4,114 but an in-depth understanding of the 
causes of pain, groin neuroanatomy, and technical aspects 
of the initial operation are necessary to successfully manage 
these patients.1,4,12,114,116–118 These factors determine the opera-
tive options available to address chronic pain after inguinal 
hernia repair.
The neuroanatomy of the groin is complex and highly vari-
able from the retroperitoneal lumbar plexus to the terminal 
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branches exiting through the inguinal canal. Understanding 
the location of potential nerve injury is crucial.64,119 In front 
of transversalis fascia, the IIN, the visible and intramuscular 
segment of the IHN, and the inguinal segment of the genital 
branch of the GFN must be considered. These structures 
may potentially be injured during open anterior repairs 
 (tissue repair, Lichtenstein, PHS [prolene hernia system], 
and plug) and from mesh fixation during laparoscopic repair 
(TEP [totally extraperitoneal] and TAPP [transabdominal 
preperitoneal]). Behind the transversalis fascia within the 
preperitoneal space, the main trunk of the genitofemoral 
and the preperitoneal segment of genital branch of GFN are 
at risk. These must be considered during open preperitoneal 
repair (plug, PHS, and Kugel) and laparoscopic repair (TEP 
and TAPP). Finally, injury to the nerves within the retroperi-
toneal space including the main trunk of the GFN over the 
psoas muscle and the lateral femoral cutaneous nerve must 
also be considered after open and laparoscopic posterior 
repair.118,120
Recommended timing for surgical treatment of chronic 
postherniorrhaphy pain not responding to nonsurgical 
management is 6 months to 1 year after the original hernia 
repair.1,4 A systematic and thorough preoperative evaluation 
to identify the specific etiologies of pain is imperative. This 
assessment should include symptomatology, review of the 
prior operative report for technique (specifically, type of 
repair, type of mesh used, position of the mesh, method of 
fixation, and nerve handling), imaging to assess for meshoma 
or other anatomic abnormality, and response with prior 
interventions.4,13,30 Neuropathic pain isolated to the inguinal 
distribution, that was not present prior to the original opera-
tion, and with improvement from diagnostic and therapeutic 
nerve blocks has the highest likelihood of improvement with 
operative neurectomy.
Operative management for pain after inguinal surgery 
has been reported as early as 1942 with Magee121 describing 
genitofemoral causalgia as a source for post-inguinal surgery 
pain. Selective IIN, IHN, and GFN neurolysis or neurectomy, 
removal of mesh and fixation material, and revision of the 
prior herniorrhaphy are common options for treatment.122–127 
Neurolysis, which does not address ultrastructural changes of 
nerve fibers, has limited efficacy and is not recommended.4 
Simple removal of entrapping sutures or fixating devices 
while leaving the injured nerves behind is also inadequate.4 
Selective single or double neurectomy may be effective for 
some patients but does not address ultrastructural changes of 
seemingly normal appearing nerves during reoperation.122–125 
From a technical perspective, reoperating in the scarred field 
becomes increasingly more difficult and morbid for subse-
quent remedial operations. Anatomically, the significant 
variation and cross-innervation of the inguinal nerves in the 
retroperitoneum and inguinal canal make selective neurec-
tomy less reliable.4,64,119 Triple neurectomy of the IIN, IHN, 
and GFN, described in our institute in 1995, is currently a 
universally accepted surgical treatment for neuropathic pain 
refractory to conservative measures and is arguably the most 
effective option.4,12,64,116–120 Our experience has included over 
650 patients utilizing an open approach with an over 85% 
success rate and 37 cases using a laparoscopic retroperitoneal 
approach with a 92% success rate.120 Operative neurectomy 
in conjunction with removal of meshoma, when present, 
provides effective relief in the majority of patients with 
refractory inguinodynia.4,119,120
“Triple neurectomy” can be performed through an open 
approach using the groin incision of the original hernia 
operation or through a laparoscopic approach particu-
larly for pain after plug repair and open and laparoscopic 
preperitoneal repair.114 With open surgery, the IIN can be 
identified lateral to the internal ring, between the ring and 
the anterior superior iliac spine. The IHN is identified within 
the  anatomic cleavage between the external and internal 
oblique aponeurosis. The nerve is then traced proximally 
within the fibers of the internal oblique muscle to a point 
lateral to the field of the original hernia repair. Failure 
to do so may leave the injured intramuscular segment of 
the nerve behind. In those instances where the IHN has a 
subaponeurotic course, the internal oblique aponeurosis is 
split to visualize and address the hidden nerve. The inguinal 
segment of the genital branch of the GFN can be identified 
between the cord and the inguinal ligament and traced later-
ally to the internal ring where it is severed. Alternatively, 
the nerve may be visualized within the internal ring through 
the lateral crus of the ring. The nerves should be resected 
proximal to the field of original hernia repair. Although there 
are no specific data available, we recommend ligation of 
the cut ends of the nerves to avoid neuroma formation and 
insertion of the proximal cut end into the muscle to keep 
the nerve stump away from the future scarring of the opera-
tive field.4,116–118 Advantages of the open approach are the 
possibility of performing a single stage operation for triple 
neurectomy as well as plug/meshoma removal if any, repair 
of the resulting defect, resection of the main trunk of the 
GFN over psoas muscle, and resection of paravasal nerves 
within the lamina propria of the vas in case of associated 
orchialgia. The disadvantage of the approach is its complex-
ity and technical difficulty operating within the scarred field, 
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placing the spermatic cord and vascular structures at higher 
risk of compromise.
Laparoscopic retroperitoneal triple neurectomy may 
be performed through a transabdominal or extraperitoneal 
approach.120,128,129 The IIN and IHN can be identified within 
the retroperitoneal space over the quadratus lumborum 
muscle and the GFN over the psoas muscle proximal to the 
scarred operative field. Endoscopic retroperitoneal selective 
neurectomies of the GFN and IIN have been reported.128,129 
As with the open experience, laparoscopic retroperitoneal 
triple neurectomy has higher efficacy rates.120 Advantages 
of the laparoscopic approach are the ability to access the 
nerves proximal to the mesh material used during the original 
herniorrhaphy, more consistent neuroanatomy within the 
retroperitoneum, and its technical simplicity. Disadvantages 
of laparoscopic approach are not being able to remove plugs, 
if any, not being able to resect the lamina propria of the vas 
in case of associated orchialgia, and potential laxity of the 
abdominal muscles caused from proximal denervation.
It is critical to clearly explain potential benefits and 
consequences of operative intervention to manage patient 
expectations. In addition to the usual operative risks, specific 
considerations include permanent numbness, the inability 
to access or identify three nerves, abdominal wall laxity 
from partial denervation of the oblique muscles, testicular 
atrophy, numbness in the labia in females that can interfere 
with sexual sensation, and loss of a cremasteric reflex in 
male patients.4,118–120 Patients are specifically advised of the 
potential for ongoing pain and disability despite success-
ful neurectomy due to the nociceptive component of pain, 
neuroplasticity, afferent hypersensitivity, and centralization 
of pain. The development and course of deafferentation 
hypersensitivity is unpredictable but typically diminishes 
over time. This operation does not address the nociceptive 
component caused by meshoma or neuropathic testicular 
pain. These issues require serious consideration and should 
be discussed with the patient and adequately recorded.4
Recurrence and meshoma are obvious anatomic patholo-
gies amenable to surgical correction. When recurrence is 
identified, surgical correction is typically recommended 
using an alternative approach (ie, laparoscopic repair after 
initial open repair or vice versa). However, if accompanied 
by neuropathic pain, an anterior, open approach allows for 
correction of the hernia as well as access to the nerves.118 
Meshoma may cause neuropathic pain from nerve entrap-
ment, direct contact with mesh, or compressive effects.13,29 
It may also cause nociceptive pain from compression of 
adjacent structures and foreign body sensation. Imaging is 
useful to help identify meshoma and involvement of adjacent 
structures. Operative removal of the meshoma is indicated 
with the need for simultaneous neurectomy directed by the 
type of mesh, approach, symptoms, imaging, and anatomy. 
If coexisting neuropathic pain is present, all nerves within 
the reoperative field should be addressed, as neuropathy 
cannot be assessed visually, and mesh removal will often 
compromise unaffected nerves within the inguinal canal.4
Neuropathy of the nerve fibers within the lamina propria 
of the vas deferens, referred to as “paravasal nerves” and 
originating from the deep pelvic plexus, may be partially 
responsible for postherniorrhaphy orchialgia. In patients with 
groin pain associated with orchialgia, segmental resection of 
the lamina propria of the vas together with triple neurectomy 
has improved outcomes and helped in the management of 
testicular pain.118 Orchialgia, however, is a complex entity, 
and remedial surgery to correct this is less predictable and 
effective.
Conclusion
Chronic inguinodynia is a problem for which there is no uni-
versally accepted definition, etiology, classification, and sur-
gical treatment. In-depth knowledge of groin neuroanatomy is 
critical, as the best measure to address this disabling compli-
cation is prevention by refining the technique of hernia repair. 
Meticulous adherence to surgical principles, with three-nerve 
identification, preservation, or pragmatic neurectomy dur-
ing open anterior repair, decreases the incidence of chronic 
inguinodynia. Avoidance of the preperitoneal nerves below 
the iliopubic tract and limited or no mesh fixation decreases 
the risk of pain after laparoscopic herniorrhaphy.
Patients at high risk of developing CPIP should be 
 identif ied preoperatively, and preventive multimodal 
analgesia and anesthesia should be given high priority. 
Preventive measures such as peri- and postoperative gaba-
pentinoids or ketamine treatment, or infiltration of local 
anesthetic, might minimize the inflammatory cascade, 
decrease central sensitization, and prevent development of 
severe chronic pain. The recommended timing for surgical 
treatment of chronic postherniorrhaphy pain not respond-
ing to nonsurgical management is 6 months to 1 year 
after the original inguinal hernia repair. A systematic and 
thorough evaluation to identify the potential causes of pain 
is mandatory. This assessment should include symptoms, 
review of the prior operative report for technique, imaging 
to assess for meshoma or other  anatomic abnormalities, and 
thorough conservative management with pharmacologic and 
interventional modalities.
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All patients with CPIP should undergo  multidisciplinary 
treatment with evaluation by a pain specialist.  Pharmacologic 
intervention including anti-inflammatories, topical anes-
thetics, neuropathic medications, antidepressants, and 
opioid analgesics should be optimized. All patients should 
undergo diagnostic and therapeutic nerve block of the 
IIN, IHN, and GFN as appropriate. Nerve ablation and 
neuromodulation are promising interventional modalities 
that may help in the non-operative management of CPIP 
and may serve as adjunctive therapy for patients who have 
failed reoperative surgery or with centralization of pain. 
For patients with pain refractory to conservative measures, 
operative neurectomy, meshoma removal, and repair of 
recurrence may provide relief. A multidisciplinary, logical, 
stepwise approach to chronic postoperative inguinal pain 
will afford patients the greatest opportunity to minimize 
symptoms, manage pain, decrease further morbidity, and 
improve quality of life.
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